243 related articles for article (PubMed ID: 32707373)
1. Evaluation of N-phenyl-2-aminothiazoles for treatment of multi-drug resistant and intracellular Staphylococcus aureus infections.
Shahin IG; Abutaleb NS; Alhashimi M; Kassab AE; Mohamed KO; Taher AT; Seleem MN; Mayhoub AS
Eur J Med Chem; 2020 Sep; 202():112497. PubMed ID: 32707373
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and antibacterial evaluation of a novel series of synthetic phenylthiazole compounds against methicillin-resistant Staphylococcus aureus (MRSA).
Mohammad H; Reddy PV; Monteleone D; Mayhoub AS; Cushman M; Seleem MN
Eur J Med Chem; 2015 Apr; 94():306-16. PubMed ID: 25771109
[TBL] [Abstract][Full Text] [Related]
3. Alkynyl-containing phenylthiazoles: Systemically active antibacterial agents effective against methicillin-resistant Staphylococcus aureus (MRSA).
Elsebaei MM; Mohammad H; Abouf M; Abutaleb NS; Hegazy YA; Ghiaty A; Chen L; Zhang J; Malwal SR; Oldfield E; Seleem MN; Mayhoub AS
Eur J Med Chem; 2018 Mar; 148():195-209. PubMed ID: 29459278
[TBL] [Abstract][Full Text] [Related]
4. Alkoxyphenylthiazoles with broad-spectrum activity against multidrug-resistant gram-positive bacterial pathogens.
ElAwamy M; Mohammad H; Hussien A; Abutaleb NS; Hagras M; Serya RAT; Taher AT; Abouzid KA; Seleem MN; Mayhoub AS
Eur J Med Chem; 2018 May; 152():318-328. PubMed ID: 29734000
[TBL] [Abstract][Full Text] [Related]
5. β,γ-Diaryl α-methylene-γ-butyrolactones as potent antibacterials against methicillin-resistant Staphylococcus aureus.
Hamann HJ; Abutaleb NS; Pal R; Seleem MN; Ramachandran PV
Bioorg Chem; 2020 Nov; 104():104183. PubMed ID: 32971415
[TBL] [Abstract][Full Text] [Related]
6. Phenylthiazoles with nitrogenous side chain: An approach to overcome molecular obesity.
Elsebaei MM; Abutaleb NS; Mahgoub AA; Li D; Hagras M; Mohammad H; Seleem MN; Mayhoub AS
Eur J Med Chem; 2019 Nov; 182():111593. PubMed ID: 31446245
[TBL] [Abstract][Full Text] [Related]
7. Antibacterial activity of 3-methylbenzo[d]thiazol-methylquinolinium derivatives and study of their action mechanism.
Sun N; Du RL; Zheng YY; Guo Q; Cai SY; Liu ZH; Fang ZY; Yuan WC; Liu T; Li XM; Lu YJ; Wong KY
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):879-889. PubMed ID: 29722581
[TBL] [Abstract][Full Text] [Related]
8. Structure optimizing of flavonoids against both MRSA and VRE.
Wei MZ; Zhu YY; Zu WB; Wang H; Bai LY; Zhou ZS; Zhao YL; Wang ZJ; Luo XD
Eur J Med Chem; 2024 May; 271():116401. PubMed ID: 38640870
[TBL] [Abstract][Full Text] [Related]
9. Arylthiazole antibiotics targeting intracellular methicillin-resistant Staphylococcus aureus (MRSA) that interfere with bacterial cell wall synthesis.
Eid I; Elsebaei MM; Mohammad H; Hagras M; Peters CE; Hegazy YA; Cooper B; Pogliano J; Pogliano K; Abulkhair HS; Seleem MN; Mayhoub AS
Eur J Med Chem; 2017 Oct; 139():665-673. PubMed ID: 28846967
[TBL] [Abstract][Full Text] [Related]
10. From Phenylthiazoles to Phenylpyrazoles: Broadening the Antibacterial Spectrum toward Carbapenem-Resistant Bacteria.
Hammad A; Abutaleb NS; Elsebaei MM; Norvil AB; Alswah M; Ali AO; Abdel-Aleem JA; Alattar A; Bayoumi SA; Gowher H; Seleem MN; Mayhoub AS
J Med Chem; 2019 Sep; 62(17):7998-8010. PubMed ID: 31369262
[TBL] [Abstract][Full Text] [Related]
11. Anti-biofilm activity and synergism of novel thiazole compounds with glycopeptide antibiotics against multidrug-resistant staphylococci.
Mohammad H; Mayhoub AS; Cushman M; Seleem MN
J Antibiot (Tokyo); 2015 Apr; 68(4):259-66. PubMed ID: 25315757
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of 1,2,3-triazole linked 4(3H)-Quinazolinones as potent antibacterial agents against multidrug-resistant Staphylococcus aureus.
Gatadi S; Gour J; Shukla M; Kaul G; Das S; Dasgupta A; Malasala S; Borra RS; Madhavi YV; Chopra S; Nanduri S
Eur J Med Chem; 2018 Sep; 157():1056-1067. PubMed ID: 30176536
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and evaluation of new quinazolin-4(3H)-one derivatives as potent antibacterial agents against multidrug resistant Staphylococcus aureus and Mycobacterium tuberculosis.
Gatadi S; Gour J; Shukla M; Kaul G; Dasgupta A; Madhavi YV; Chopra S; Nanduri S
Eur J Med Chem; 2019 Aug; 175():287-308. PubMed ID: 31096152
[TBL] [Abstract][Full Text] [Related]
14. Diphenylurea derivatives for combating methicillin- and vancomycin-resistant Staphylococcus aureus.
Eissa IH; Mohammad H; Qassem OA; Younis W; Abdelghany TM; Elshafeey A; Abd Rabo Moustafa MM; Seleem MN; Mayhoub AS
Eur J Med Chem; 2017 Apr; 130():73-85. PubMed ID: 28249208
[TBL] [Abstract][Full Text] [Related]
15. Oritavancin Combinations with β-Lactams against Multidrug-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococci.
Smith JR; Yim J; Raut A; Rybak MJ
Antimicrob Agents Chemother; 2016 Apr; 60(4):2352-8. PubMed ID: 26833159
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and antibacterial activity of demethylvancomycin analogues against drug-resistant bacteria.
Chang J; Zhang SJ; Jiang YW; Xu L; Yu JM; Zhou WJ; Sun X
ChemMedChem; 2013 Jun; 8(6):976-84. PubMed ID: 23576378
[TBL] [Abstract][Full Text] [Related]
17. Design and synthesis of 2-aminothiazole based antimicrobials targeting MRSA.
Annadurai S; Martinez R; Canney DJ; Eidem T; Dunman PM; Abou-Gharbia M
Bioorg Med Chem Lett; 2012 Dec; 22(24):7719-25. PubMed ID: 23116888
[TBL] [Abstract][Full Text] [Related]
18. Activity of the thiopeptide antibiotic nosiheptide against contemporary strains of methicillin-resistant Staphylococcus aureus.
Haste NM; Thienphrapa W; Tran DN; Loesgen S; Sun P; Nam SJ; Jensen PR; Fenical W; Sakoulas G; Nizet V; Hensler ME
J Antibiot (Tokyo); 2012 Dec; 65(12):593-8. PubMed ID: 23047246
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, and evaluation of N
Kim T; Choi SY; Bae HW; Kim HS; Jeon H; Oh H; Ahn SH; Lee J; Suh YG; Cho YH; Kim SH
Eur J Med Chem; 2024 Jun; 272():116454. PubMed ID: 38704937
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of meropenem/piperacillin/tazobactam triple combination therapy against clinical isolates of Staphylococcus aureus, Staphylococcus epidermidis, Staphylococcus pseudintermedius and vancomycin-resistant Enterococcus spp.
Yoneda A; Thänert R; Burnham CD; Dantas G
Int J Antimicrob Agents; 2020 Feb; 55(2):105864. PubMed ID: 31870598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
